PC
BLUE

Passport Capital’s bluebird bio BLUE Stock Holding History

Passport Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,316
Closed -$19.6M – 100
2016
Q3 		$19.6M Buy
+22,316
New +$16.2M 0.41% 43
2015
Q3 		– Sell
-16,621
Closed -$36.2M – 139
2015
Q2 		$36.2M Buy
+16,621
New +$33.9M 0.73% 30

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Passport Capital's BLUE Position: Q4 2016 in Review

Passport Capital sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 22,316 shares — an estimated $19.6M sold.

Passport Capital first reported a position in BLUE in Q2 2015 and held it in 2 quarters. The position peaked at $36.2M in Q2 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

  • Passport Capital reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
  • Passport Capital sold 22,316 bluebird bio shares in Q4 2016, an estimated $19.6M.
  • Passport Capital first reported a position in bluebird bio in Q2 2015 and held it in 2 quarters.
  • Passport Capital's bluebird bio position peaked at $36.2M in Q2 2015.
  • 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on Passport Capital's 13F filing for Q4 2016, filed 14 Feb 2017.